← Browse by Condition
Medical Condition

acute lymphocytic leukemia all

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT07053059 Phase 2
Recruiting

Phase 2 Study Assessing the Clinical Activity and Safety of Obecabtagene Autoleucel as a Consolidation in Patients With Newly Diagnosed High-risk B-cell Acute Lymphocytic Leukemia (ALL)

Enrollment
30 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
View Trial →